Edition:
United Kingdom

Ipsen SA (IPN.PA)

IPN.PA on Paris Stock Exchange

117.90EUR
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
€117.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,934
52-wk High
€155.95
52-wk Low
€99.00

Chart for

About

Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes... (more)

Overall

Beta: 0.75
Market Cap(Mil.): €9,633.51
Shares Outstanding(Mil.): 83.66
Dividend: 0.85
Yield (%): 0.74

Financials

  IPN.PA Industry Sector
P/E (TTM): 44.34 31.13 33.63
EPS (TTM): 2.60 -- --
ROI: 11.19 15.55 15.02
ROE: 16.34 16.92 16.60

French pharma group Ipsen closes in on its next drug deals

LONDON French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of biotech stocks as increasing deal opportunities, its chief executive said on Wednesday.

14 Nov 2018

French pharma group Ipsen closes in on its next drug deals

LONDON French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of biotech stocks as increasing deal opportunities, its chief executive said on Wednesday.

14 Nov 2018

French pharma group Ipsen closes in on its next drug deals

LONDON, Nov 14 French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of biotech stocks as increasing deal opportunities, its chief executive said on Wednesday.

14 Nov 2018

BRIEF-Ipsen Presents Real-World Pancreatic Cancer Data On ONIVYDE

* REPORTED ON SUNDAY REAL-WORLD PANCREATIC CANCER DATA ON ONIVYDE

22 Oct 2018

Earnings vs. Estimates